$0.000001
At close: May 19, 11:13 AM EDT
Comments
Loading...
Rising Biosciences Analyst Ratings and Price Targets | OTC:RBII | Benzinga
Rising Biosciences Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Rising Biosciences Corp from these most-recent analyst ratings.
Analyst Ratings for Rising Biosciences
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Rising Biosciences (RBII) stock?
There is no price target for Rising Biosciences
What is the most recent analyst rating for Rising Biosciences (RBII)?
There is no analyst for Rising Biosciences
When was the last upgrade for Rising Biosciences (RBII)?
There is no last upgrade for Rising Biosciences
When was the last downgrade for Rising Biosciences (RBII)?
There is no last downgrade for Rising Biosciences.
When is the next analyst rating going to be posted or updated for Rising Biosciences (RBII)?
There is no next analyst rating for Rising Biosciences.
Is the Analyst Rating Rising Biosciences (RBII) correct?
There is no next analyst rating for Rising Biosciences.
Browse analyst ratings and price targets on all stocks.
